Soleno Therapeutics, Inc. · NASDAQ:SLNO
State Street Corp reported a 5.20% stake in Soleno Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp reported a 5.20% stake in Soleno Therapeutics, Inc., 2,680,802 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 2,680,802
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.20% | 2,680,802 |